Ludwig, H; Kasparu, H; Greil, R; Leitgeb, C; Muldur, E; Rauch, E; Zojer, N; Autzinger, EM; Linkesch, W; Kuhr, T; Pour, L; Adam, Z; .
Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
[Poster]
Web of Science